EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Altered Pharmacokinetics and Delayed Sputum Conversion in Tuberculosis Patients Co‐Infected With HIV

Aung Pyae Phyo iD, Richard M Hoglund, Makoto Saito, Sein Sein Thi, Lei Lei Swe, Palang Chotsiri, Htet Ko Ko Aung, Win Pa Pa Tun, Banyar Maung Maung, Chanapat Pateekham, Wanitda Watthanaworawit, Gornpan Gornsawun und 3 weitere

Tropical Medicine & International Health · 2026-09 · 31 (9) · 1261-1272

DOI: 10.1111/tmi.70165 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Tropical Medicine & International Health, online erschienen am 19.05.2026. Verfasst von Aung Pyae Phyo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Shoklo Malaria Research Unit, Mahidol University, Mae Ramat, Tak, Thail…. Hauptthemen laut MEDLINE: Sputum, Antitubercular Agents, HIV Infections, Coinfection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HIV co‐infection affects host responses and pharmacokinetics (PK) of tuberculosis (TB) treatment. This study assessed the PK of first‐line anti‐TB drugs and clinical outcomes in patients with and without HIV co‐infection.

Methods

In this prospective observational study, 61 adults with sputum‐positive pulmonary TB, either confirmed by microscopy or GeneXpert, were enrolled, including 24 with HIV co‐infection and 37 without. All HIV‐positive participants were antiretroviral‐naïve at enrolment. Standard anti‐TB therapy was given, and PK assessments were conducted on Day 1 and Week 6. Efavirenz‐based antiretroviral therapy (ART) began at a median of Day 21. Clinical outcomes, sputum conversion, and adverse events were monitored.

Results

At baseline, patients with HIV co‐infection had reduced clearance of isoniazid and ethambutol, reflected by slower elimination rates. These differences resolved by Week 6 and were not significantly impacted by ART initiation. Logistic regression showed that HIV‐positive status (OR = 14.25, 95% CI: 1.22–166.37, p = 0.03), and higher baseline sputum bacillary load (OR = 3.92, 95% CI: 1.5–10.5, p = 0.006) were independently associated with delayed sputum conversion beyond 8 weeks. Baseline CRP showed an inverse association after adjustment, but this did not reach statistical significance (OR = 0.98, 95% CI: 0.96–1.00, p = 0.06).

Conclusion

HIV co‐infection was associated with altered early PK of isoniazid and ethambutol although these differences were less apparent by Week 6. HIV‐positive status and higher baseline sputum bacillary load were associated with delayed sputum conversion. Although some pharmacokinetic differences were statistically significant, their clinical relevance remains uncertain, and the current data do not support dose adjustment. These findings suggest early pharmacokinetic variability in TB–HIV co‐infected patients and support further investigation in adequately powered exposure–response studies. Trial Registration: ClinicalTrials.gov : NCT02457208

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SputumAntitubercular AgentsHIV InfectionsCoinfectionTuberculosis, PulmonaryHumansFemaleMaleAdultProspective StudiesEthambutolIsoniazidMiddle AgedAlkynesBenzoxazinesCyclopropanesAnti-HIV Agents

Stichwörter der Autor:innen

HIV‐infectionethambutolisoniazidnon‐compartmental analysis (NCA)pharmacokineticspulmonary tuberculosispyrazinamiderifampicinsputum conversion

Substanzen

Antitubercular AgentsEthambutolIsoniazidAlkynesefavirenzBenzoxazinesCyclopropanesAnti-HIV Agents

Autor:innen und Institutionen

  • Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Shoklo Malaria Research Unit, Mahidol University, Mae Ramat, Tak, Thailand.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Division of Infectious Diseases, University of Tokyo, Tokyo, Japan.

ORCID-Profile: Aung Pyae Phyo

Förderung

  • Wellcome Trust

Zitieren

APA

Phyo, A. P., Hoglund, R. M., Saito, M., Thi, S. S., Swe, L. L., Chotsiri, P., Aung, H. K. K., Tun, W. P. P., Maung, B. M., Pateekham, C., Watthanaworawit, W., Gornsawun, G., White, N. J., Nosten, F., & Tarning, J. (2026). Altered Pharmacokinetics and Delayed Sputum Conversion in Tuberculosis Patients Co‐Infected With HIV. Tropical Medicine & International Health, 31(9), 1261-1272. https://doi.org/10.1111/tmi.70165

Vancouver

Phyo AP, Hoglund RM, Saito M, Thi SS, Swe LL, Chotsiri P, et al. Altered Pharmacokinetics and Delayed Sputum Conversion in Tuberculosis Patients Co‐Infected With HIV. Tropical Medicine & International Health. 2026;31(9):1261-1272. doi:10.1111/tmi.70165

BibTeX
@article{Phyo2026,
  author = {Phyo, Aung Pyae and Hoglund, Richard M and Saito, Makoto and Thi, Sein Sein and Swe, Lei Lei and Chotsiri, Palang and Aung, Htet Ko Ko and Tun, Win Pa Pa and Maung, Banyar Maung and Pateekham, Chanapat and Watthanaworawit, Wanitda and Gornsawun, Gornpan and White, Nicholas J and Nosten, Francois and Tarning, Joel},
  title = {Altered Pharmacokinetics and Delayed Sputum Conversion in Tuberculosis Patients Co‐Infected With HIV},
  journal = {Tropical Medicine & International Health},
  year = {2026},
  volume = {31},
  number = {9},
  pages = {1261--1272},
  doi = {10.1111/tmi.70165}
}
Kostenlos starten →